Equity markets have an extra spring in their step

Traders' attention is dominated by global manufacturing PMI data releases.

London
Source: Bloomberg

The FTSE 100 has added over 500 points in the last two weeks, and as we move into Spring, it appears determined to put the dark days behind it. As impressive as this rally has been, almost all of the major European equity markets still remain well below levels they started the year at.

Although Chinese manufacturing data missed the mark, European countries have broadly hit the mark, while the eurozone figure has even outperformed expectations. There is always one exception to the rule and the soft UK figures have painted it as the odd one out.

Barclays is the latest of the blue chip financials to report, and although it has posted full-year pre-tax profits of £5.4 billion this is still 2% lower than expectations. This has triggered fresh asset stripping plans, with the disposal of its African subsidiary the latest target of cost-cutting.

It’s nice to be wanted, and the London Stock Exchange now finds itself with two admirers following the news that the Intercontinental Exchange is looking to put together a counter bid to the one already on the table from Deutsche Boerse. As both admirers chase the price higher, shareholders have sat back and watched as the LSE share price has jumped another 7.45% in morning trading. Direct Line might be fearful of Brexit headwinds but it has still managed to post full year pretax profits 5.6% above expectations, ensuring the markets have added another 2.86% to the share price.

Gold continues to flirt with the idea of being outwardly bullish as it has crept back up to $1240, keeping the pressure on the shorts and encouraging the bulls.

Although GBP/USD has had a quiet 24-hours, it just means we are that much closer to some politician voicing their views on the Brexit and sending the FX markets into a fresh round of speculation. 

FTSE risers and fallers (as of 9:30am)

Company % change Index points
British American Tobacco +1.22 +3.49
Imperial Brands +2.07 +2.89
London Stock Exchange +7.62 +2.48
Reckitt Benckiser +1.51 +2.54
Rio Tinto +2.55 +2.32

 

Company % change Index points
Barclays -9.24 -10.38
Ashtead Group -16.07 -2.91
Glencore -4.24 -2.57
AstraZeneca -0.73 -1.48
Royal Dutch Shell

-0.33

-0.81


The day ahead

Economic data:

1.30pm – Canada GDP (Q4): QoQ expected -0.19%, prior 0.6%. YoY expected -0.3%, prior 2.3%.

3pm – US ISM manufacturing (February): manufacturing is tipped to come at 48.45, up from 48.2.

4.30am:  Fed member William Dudley is speaking in Hangzhou

Corporate reporting:

Full year earnings: Barclays, Direct Line Insurance Group, Glencore, Moneysupermarket.com Group, Regus, Taylor Wimpey, Tullett Prebon, Fresnillo, Greggs, Just Eat

Half/Quarterly earnings: Ashtead Group

Trading update: General Motors Co, Tata Motors Ltd

IGA, may distribute information/research produced by its respective foreign marketing partners within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

This information/research prepared by IGA or IGA Group is intended for general circulation. It does not take into account the specific investment objectives, financial situation or particular needs of any particular person. You should take into account your specific investment objectives, financial situation or particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. In addition to the disclaimer above, the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

See important Research Disclaimer.